Fig. 1.
Fig. 1. Localization of VEGFR-2 and VEGFR-3. / (A) E9.5 embryos were stained with anti-CD31 antibody to visualize all endothelial cells. (B) Embryos stained with anti–VEGFR-2 antibody. The pattern of VEGFR-2 expression was similar to that seen in panel A. (C) LacZ staining in VEGFR-3+/LacZ embryos at E9.5. VEGFR-3 expression was detected mainly in large vessels. (D) Flow cytometric analysis of VEGFR-2 and VEGFR-3 in PECAM-1/CD31+cells. After FACS-gal staining, these cells were stained with VEGFR-2 and CD31 antibodies (see “Materials and methods”). The numbers indicate the percentage of cells that appeared in each quadrant. The result shown is representative of 3 independent experiments.

Localization of VEGFR-2 and VEGFR-3.

(A) E9.5 embryos were stained with anti-CD31 antibody to visualize all endothelial cells. (B) Embryos stained with anti–VEGFR-2 antibody. The pattern of VEGFR-2 expression was similar to that seen in panel A. (C) LacZ staining in VEGFR-3+/LacZ embryos at E9.5. VEGFR-3 expression was detected mainly in large vessels. (D) Flow cytometric analysis of VEGFR-2 and VEGFR-3 in PECAM-1/CD31+cells. After FACS-gal staining, these cells were stained with VEGFR-2 and CD31 antibodies (see “Materials and methods”). The numbers indicate the percentage of cells that appeared in each quadrant. The result shown is representative of 3 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal